| TrivarX Ltd (TRI) ORDINARY FULLY PAID |
Health Care |
$18 |
CRO Engaged to Advance Stabl-Im Phase 1 Trial
|
22 May 2026 9:36AM |
$0.029 |
$0.016 |
fallen by
43.86%
|
|
TRI - Price-sensitive ASX Announcement
Full Release
Key Points
- TrivarX Limited engages Beyond Drug Development to progress the Phase 1 safety trial for Stabl-Im.
- Stabl-Im is a proprietary MRI-based imaging platform designed to visualize tumor activity without radioactive tracers.
- The Phase 1 trial will evaluate the safety and tolerability of Stabl-Im in healthy human volunteers.
- Beyond Drug Development brings extensive expertise in early-phase clinical development and regulatory strategy.
- The engagement is a significant milestone in advancing Stabl-Im toward Phase 2 studies and broader oncology applications.
- TrivarX targets commencement of the Phase 1 safety study in the second half of the calendar year 2026.
- Dr. Danielle Meyrick, CEO of TrivarX, highlights the strategic importance of the collaboration with Beyond Drug Development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$1,074 |
Update - Notification of buy-back - IPH
|
22 May 2026 9:35AM |
$3.760 |
$4.190 |
risen by
11.44%
|
|
| Bubs Australia Limited (BUB) ORDINARY FULLY PAID |
Consumer Staple |
$77 |
Initial Director's Interest Notice - LTM
|
22 May 2026 9:35AM |
$0.092 |
$0.086 |
fallen by
6.52%
|
|
| Black Pearl Group Limited (BPG) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$35 |
Notice of Full Year Result Announcement
|
22 May 2026 9:34AM |
$0.500 |
$0.360 |
fallen by
28%
|
|
| Blaze Minerals Limited (BLZ) ORDINARY FULLY PAID |
Energy |
$3 |
Exploration Update at Dinokwe
|
22 May 2026 9:30AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
BLZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Discovery of a copper-in-soil anomaly at the Krokodil Prospect.
- Significant copper, lead, and zinc concentrations found in rock-chip samples.
- The anomaly spans over 1000m by 100m within the Dinokwe Project.
- Located within the Limpopo Mobile Belt, known for base metal deposits.
- Plan to undertake an extensive trenching campaign to further explore the area.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$15 |
Appointment of Lead Manager to advance Critical Minerals IPO
|
22 May 2026 9:29AM |
$0.016 |
$0.018 |
risen by
12.50%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Godolphin Resources Limited appointed MST Financial as Lead Manager and Financial Adviser for the spin-out of the Narraburra Rare Earths Project.
- The spin-out involves creating a new company, Matrix Critical Minerals Limited, to hold the Narraburra Project and other exploration assets.
- Matrix will become an ASX-listed entity, with the listing expected in the second half of 2026.
- The project hosts a large-scale mineral resource with significant exploration potential, focusing on rare earth elements and yttrium.
- Matrix's board features experienced professionals, including Christopher Gibbs as Executive Chairman and Jeneta Owens as Non-Executive Director.
- A priority offer and in-specie distribution of Matrix shares are planned for existing Godolphin shareholders.
- The Narraburra project benefits from high concentrations of dysprosium, terbium, and yttrium, critical minerals with supply concerns due to Chinese export controls.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$96 |
Update - Notification of buy-back - CAM
|
22 May 2026 9:28AM |
$0.695 |
$0.680 |
fallen by
2.16%
|
|
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$7 |
Trading Halt
|
22 May 2026 9:28AM |
$0.029 |
$0.019 |
fallen by
34.48%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Bio-Gene Technology Limited
- Trading halt is pending an announcement by BGT
- Trading halt effective from 22 May 2026
- Expected to end by 26 May 2026 or upon announcement
- Reason for the halt: proposed capital raising
- Request submitted to ASX Compliance Pty Ltd
- BGT's fully paid ordinary shares affected
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,363 |
Cleansing Notice
|
22 May 2026 9:28AM |
$0.235 |
$0.265 |
risen by
12.77%
|
|
| Arafura Rare Earths Ltd (ARU) ORDINARY FULLY PAID |
Materials |
$1,153 |
Arafura Launches A$350m Placement and A$25m SPP
|
22 May 2026 9:27AM |
$0.310 |
$0.190 |
fallen by
38.71%
|
|
ARU - Price-sensitive ASX Announcement
Full Release
Key Points
- Arafura launches A$350 million placement and A$25 million SPP.
- Placement conducted in two tranches with Hancock Prospecting committing A$85 million.
- Funds to be used for Nolans Project development and corporate expenses.
- Project supported by Export Finance Australia and other financial entities.
- Arafura secured 93% of its binding offtake target for NdPr Oxide.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,363 |
Application for quotation of securities - EQR
|
22 May 2026 9:27AM |
$0.235 |
$0.265 |
risen by
12.77%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$42 |
Azer-cel Data from CAR T naive cohort in ASCO 2026 abstract
|
22 May 2026 9:27AM |
$0.096 |
$0.085 |
fallen by
11.46%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Azer-cel demonstrates promising clinical activity across CD19 B-cell malignancies including MZL and CLL.
- Encouraging response rates, robust CAR T-cell expansion, and a manageable safety profile observed.
- Overall response rate (ORR) was 81% among evaluable patients in the CAR T naïve cohort.
- Azer-cel Phase 1b study data presented in ASCO 2026 abstract.
- Imugene to present updated data in an oral presentation at the ASCO Annual Meeting.
- Imugene's trial aims to target specific indications where Azer-cel can have a strong clinical impact.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lefroy Exploration Limited (LEX) ORDINARY FULLY PAID |
Materials |
$30 |
Proposed issue of securities - LEX
|
22 May 2026 9:27AM |
$0.125 |
$0.110 |
fallen by
12%
|
|
| Lefroy Exploration Limited (LEX) ORDINARY FULLY PAID |
Materials |
$30 |
$3.6 Million Placement for Evaluation of Mt Martin Deposit
|
22 May 2026 9:27AM |
$0.125 |
$0.110 |
fallen by
12%
|
|
LEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lefroy Exploration Limited (ASX: LEX) announced a $3.6 million placement to accelerate the evaluation of the Mt Martin Gold Deposit.
- The placement involves issuing 28.8 million fully paid ordinary shares at $0.125 per share.
- Directors of Lefroy committed $317,570 to the placement, subject to shareholder approval.
- The funds will expedite scoping studies and activities at Mt Martin and the high-grade gold core at Burns.
- Proceeds will also be used for drilling and resource estimation work at Burns.
- Bridge Street Capital Partners Pty Ltd acted as the Sole Lead Manager for the Placement.
- Lefroy acquired 100% mineral rights to the Mt Martin Gold Mine from Franco-Nevada Pty Ltd in May 2023.
- The Mt Martin Gold Mine has a mineral resource estimate of 9.1Mt grading 1.6g/t Au for 460,000 ounces of gold.
- The placement supports the continuation of exploration and evaluation amidst awaiting cash flow from the Lucky Strike Profit Share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Avira Resources Ltd (AVW) ORDINARY FULLY PAID |
Materials |
$4 |
Siteworks Commence At The High-Grade Mt Cattlin Gold Project
|
22 May 2026 9:24AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
AVW - Price-sensitive ASX Announcement
Full Release
Key Points
- Siteworks have commenced at Mt Cattlin Gold Project.
- Avira's inaugural 4,500-metre RC drilling program is set to begin.
- The drilling targets four prospects: Sirdar, Maori Queen, Ellendale, Plantagenet.
- Drill Safe Services Pty Ltd has been contracted for drilling.
- Regulatory, environmental, and heritage approvals secured.
- Historical high-grade gold intersections confirmed at Mt Cattlin.
- The project aims for a maiden Mineral Resource Estimate by Q4 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GWA Group Limited (GWA) ORDINARY FULLY PAID |
Industrials |
$650 |
Update - Notification of buy-back - GWA
|
22 May 2026 9:24AM |
$2.090 |
$2.450 |
risen by
17.22%
|
|
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,363 |
Application for quotation of securities - EQR
|
22 May 2026 9:23AM |
$0.235 |
$0.265 |
risen by
12.77%
|
|
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$8 |
Notice of GM & Proxy Form & Access Letter
|
22 May 2026 9:23AM |
$0.046 |
$0.027 |
fallen by
41.30%
|
|
| SPC Global Holdings Ltd (SPG) ORDINARY FULLY PAID |
Consumer Staple |
$116 |
Section 708A Cleansing Statement
|
22 May 2026 9:21AM |
$0.105 |
$0.097 |
fallen by
7.62%
|
|
| Asara Resources Limited (AS1) ORDINARY FULLY PAID |
Materials |
$240 |
More outstanding Results at the Kada Gold Project
|
22 May 2026 9:21AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
AS1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Northeast high-grade extension delivers strong results.
- Significant drilling intercepts include 40m @ 4.5g/t Au.
- Drillhole MSRC26-077B confirms optimal drill orientation.
- Phase 2 Inferred program intersects continuous mineralisation.
- Resource growth strategy focuses on Indicated and Inferred expansion.
- Asara holds 75% interest in the Kada Gold Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$119 |
Completion of Red Metal Distribution In-Specie
|
22 May 2026 9:21AM |
$0.350 |
$0.380 |
risen by
8.57%
|
|
| NexGen Energy (Canada) Ltd (NXG) CDI 1:1 FOREIGN EXEMPT TSX |
Energy |
$1,782 |
NexGen Files Management Information Circular - 2026 AM
|
22 May 2026 9:19AM |
$14.860 |
$12.940 |
fallen by
12.92%
|
|
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$82 |
Update - Notification of buy-back - ATG
|
22 May 2026 9:17AM |
$0.255 |
$0.280 |
risen by
9.80%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,598 |
2026 Q2 Investor Webinar Presentation
|
22 May 2026 9:17AM |
$1.305 |
$1.625 |
risen by
24.52%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$34 |
New Clinical Evidence for OncoSil Device Presented at ASCO
|
22 May 2026 9:14AM |
$0.510 |
$1.110 |
risen by
117.65%
|
|
Call 1300 880 160
Start a chat
Schedule a call
